Endpoints News 2025-12-18 Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
Endpoints News 2025-12-18 After year of triumph, Insmed stumbles with chronic rhinosinusitis fail, brings in new asset
Endpoints News 2025-12-18 Lilly’s orforglipron is the first oral obesity therapy to show its worth in the maintenance setting
Endpoints News 2025-12-17 European Commission unveils EU Biotech Act as it lags behind other countries
Endpoints News 2025-12-17 RFK Jr. adds conditions to newborn screening list after committee termination
Endpoints News 2025-12-17 Several companies expected to announce ‘most favored nation’ deals Friday at White House